Jasper Therapeutics

(NASDAQ) JSPR

Current Price$0.49

Market Cap$13.69M

Since IPO (2020)-100%

5 YearN/A

1 Year-91%

1 Month-46%

Jasper Therapeutics Financials at a Glance

Market Cap

$13.69M

Revenue (TTM)

$0.00

Net Income (TTM)

-$55.73M

EPS (TTM)

-$3.23

P/E Ratio

-0.15

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$0.49

Volume

2,246

Open

$0.50

Price

$0.49

Volume

2,246

Open

$0.50

Previous Close

$0.49

Daily Range

$0.48 - $0.52

52-Week Range

$0.42 - $7.19

Estimated Earnings Date

May 8, 2026

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$0.49

Volume

2,246

Open

$0.50

Previous Close

$0.49

Daily Range

$0.48 - $0.52

52-Week Range

$0.42 - $7.19

Estimated Earnings Date

May 8, 2026

JSPR News

Jasper Reports Wider Loss in Fiscal Q2

Motley Fool Markets TeamAug 13, 2025

Why Jasper Therapeutics Stock Is Jumping Today

Cory RenauerOct 13, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Jasper Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jeet Mahal, MBA

Website

www.jaspertherapeutics.com

Headquarters

Redwood City, CA 94065, US

JSPR Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-523.04%

Return on Capital

-1494.95%

Return on Assets

-263.09%

Earnings Yield

-6.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.69M

Shares Outstanding

28.00M

Volume

2.25K

Avg. Volume

538.09K

Financials (TTM)

Gross Profit

-$21.00K

Operating Income

-$73.03M

EBITDA

-$54.94M

Operating Cash Flow

-$68.87M

Capital Expenditure

-$7.00K

Free Cash Flow

-$68.87M

Cash & ST Invst.

$14.14M

Total Debt

$757.00K

Jasper Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$21.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$13.69M

N/A

Market Cap/Employee

$622.29K

N/A

Employees

N/A

Net Income

-$1.17M

+94.5%

EBITDA

-$1.15M

+94.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$14.14M

-71.0%

Total Debt

$757.00K

-70.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$757.00K

-58.7%

Return on Assets

-2.63%

N/A

Return on Invested Capital

-5.99%

N/A

Free Cash Flow

-$14.55M

+36.3%

Operating Cash Flow

-$14.55M

+36.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CELUCelularity Inc.

CELUCelularity Inc.$0.68-3.37%

PSTVPlus Therapeutics, Inc.

PSTVPlus Therapeutics, Inc.$3.96-2.94%

NXTCNextCure, Inc.

NXTCNextCure, Inc.$1.77-2.21%

MURAMural Oncology plc

MURAMural Oncology plc$2.04+0.00%

GBIOGeneration Bio Co.

GBIOGeneration Bio Co.$5.34+0.00%

SABSSAB Biotherapeutics, Inc.

SABSSAB Biotherapeutics, Inc.$3.84-0.78%

BTAIBioXcel Therapeutics, Inc.

BTAIBioXcel Therapeutics, Inc.$1.31+3.97%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WENWendy's

WENWendy's$7.86+0.26%

AALAmerican Airlines Group

AALAmerican Airlines Group$17.44+0.08%

NOKNokia

NOKNokia$13.81+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.87-0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.27+0.01%

PATHUiPath

PATHUiPath$10.31+0.01%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$154.54-0.01%

Questions About JSPR

What is the current price of Jasper Therapeutics?

Jasper Therapeutics is trading at $0.49 per share.

What is the 52-week range for Jasper Therapeutics?

Over the past 52 weeks, Jasper Therapeutics has traded between $0.42 and $7.19.

How much debt does Jasper Therapeutics have?

As of the most recent reporting period, Jasper Therapeutics reported total debt of $757.00K.

How much cash does Jasper Therapeutics have on hand?

Jasper Therapeutics reported $14.14M in cash and cash equivalents in its most recent financial results.

What is Jasper Therapeutics’s dividend yield?

Jasper Therapeutics does not currently have a dividend yield.

Jasper Therapeutics

Jasper Therapeutics Financials at a Glance

JSPR News

Jasper Reports Wider Loss in Fiscal Q2

Why Jasper Therapeutics Stock Is Jumping Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Jasper Therapeutics

JSPR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Jasper Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About JSPR

What is the current price of Jasper Therapeutics?

What is the 52-week range for Jasper Therapeutics?

How much debt does Jasper Therapeutics have?

How much cash does Jasper Therapeutics have on hand?

What is Jasper Therapeutics’s dividend yield?

Premium Investing Services